<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) developed in four patients 66 to 157 months following the diagnosis of nodular poorly differentiated lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:chebi fb="6" ids="53413">PDL</z:chebi>-N) </plain></SENT>
<SENT sid="1" pm="."><plain>The ANLL was signalled by increasing <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A characteristic cytologic pattern of the <z:hpo ids='HP_0001909'>leukemia</z:hpo> was found </plain></SENT>
<SENT sid="3" pm="."><plain>In each patient, a <z:e sem="disease" ids="C0235580" disease_type="Neoplastic Process" abbrv="">panmyelosis</z:e> was present with striking morphologic abnormalities in leukocytes, erythrocytes and megakaryocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Marrow cytogenetic studies demonstrated abnormalities in <z:hpo ids='HP_0000001'>all</z:hpo> three patients studied </plain></SENT>
<SENT sid="5" pm="."><plain>One of three patients treated with intensive chemotherapy obtained a complete remission </plain></SENT>
<SENT sid="6" pm="."><plain>When long term survivors with <z:chebi fb="6" ids="53413">PDL</z:chebi>-N develop increasing <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, morphologic and cytogenetic marrow examinations are indicated to distinguish progressive <z:hpo ids='HP_0002665'>lymphoma</z:hpo> from therapy-induced <z:e sem="disease" ids="C0854467" disease_type="Disease or Syndrome" abbrv="">myelosuppression</z:e> or ANLL </plain></SENT>
</text></document>